DREXEL UNIVERSITY IN PHILADELPHIA OPENS MEDICAL CANNABIS RESEARCH CENTER

After Pennsylvania’s medical cannabis law set forth that medical schools could be designated as Academic Clinical Research Centers (ACRC), Drexel University started operations at the Medical Cannabis Research Center in 2020, aiming to conduct clinical, public health and translational research studies along with Argonomed Biologics LLC, these two organizations entered into an 8-year, 15.5-million-dollar contract.

In addition, funding for annual pilot trials is being considered in order to explore the efficacy of Cannabis as a treatment for other conditions such as autism and opioid addiction.

This research center leads to the possibility of using Cannabis as a consolidated treatment for several diseases and to study on a larger scale the safety and efficacy analysis of the plant.

Source: https://drexel.edu/about/glance/, https://drexel.edu/cannabis-research/about/mission-goals/

Written by Dr. Carmen de la Rocha D. in Plant Biotechnology, CINVESTAV-Irapuato - Master of Science in Biochemical Engineering, ITC - Bachelor of Science in Nutrition and Food Science, IBERO, León - Supervisor of the Department of Development CidVID - Professor of Subject B, CUCS UdeG Member of the National System of Researchers, level I.